Current position:Home >Product >
1L-6-HYDROXYMETHYL-CHIRO-INOSITOL 2-(R)-2-O-METHYL-3-O-OCTADECYLCARBONATE
1L-6-HYDROXYMETHYL-CHIRO-INOSITOL 2-(R)-2-O-METHYL-3-O-OCTADECYLCARBONATE(1004990-28-6)
- Name: 1L-6-HYDROXYMETHYL-CHIRO-INOSITOL 2-(R)-2-O-METHYL-3-O-OCTADECYLCARBONATE
- Synonyms:AKT INHIBITOR;AKT protein kinase inhibitor;1L-6-HYDROXYMETHYL-CHIRO-INOSITOL 2-(R)-2-O-METHYL-3-O-OCTADECYLCARBONATE
- Molecular Formula:C20H22F2N6O
- Molecular Weight:400.43
- CAS Registry Number:1004990-28-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 190447-31-5/2(1H)-Isoquinolinebutanoic acid, β-[[2-[3-[4-(aminoiminomethyl)phenyl]-4,5-dihydro-5-isoxazolyl]acetyl]amino]-3,4-dihydro-γ-oxo-, (βS)-
- 220798-08-3/Acetic acid, 2-[3-[[[3-(aMinoiMinoMethyl)phenyl][2-[[4-[1-(1-iMinoethyl)-4-piperidinyl]phenyl]aMino]-2-oxoethyl]aMino]Methyl]phenoxy]-, (Hydrochloride) (1:2)
- 220798-32-3/Acetic acid, 2-[3-[[[3-(aminoiminomethyl)phenyl][2-[[4-[1-(1-iminoethyl)-4-piperidinyl]phenyl]amino]-2-oxoethyl]amino]methyl]phenoxy]-, sulfate (1:1)
- 353228-03-2/2-Naphthalenecarboximidamide, 7-[[2,3-dihydro-7-[[1-(1-iminoethyl)-4-piperidinyl]oxy]-3-oxo-4H-1,4-benzoxazin-4-yl]methyl]-
- 364614-38-0/[1,1'-Biphenyl]-3-carboximidamide, 3'-[[[4-[[1-(1-iminoethyl)-4-piperidinyl]oxy]phenyl](methylsulfonyl)amino]methyl]-
- 364614-57-3/Benzo[b]thiophene-5-carboximidamide, 2-[[[4-[[1-(1-iminoethyl)-4-piperidinyl]oxy]phenyl](methylsulfonyl)amino]methyl]-
- 405887-01-6/Acetic acid, 2-[[2-[(1E)-2-[5-(aminoiminomethyl)-2-hydroxyphenyl]ethenyl]-2,3-dihydro-5-[[1-(1-iminoethyl)-4-piperidinyl]oxy]-1H-indol-1-yl]sulfonyl]-
- 732236-85-0/Acetic acid, 2-[[(2R)-2-[7-(aminoiminomethyl)-2-naphthalenyl]-2,3-dihydro-5-[[1-(1-iminoethyl)-4-piperidinyl]oxy]-1H-indol-1-yl]sulfonyl]-
- 319450-26-5/2-Naphthalenecarboximidamide, 7-[(2R)-1-(ethylsulfonyl)-2,3-dihydro-5-[[1-(1-iminoethyl)-4-piperidinyl]oxy]-1H-indol-2-yl]-, hydrochloride (1:2)
- 753439-35-9/2-Naphthalenecarboximidamide, 7-[(2R)-1-(ethylsulfonyl)-2,3-dihydro-5-[[1-(1-iminoethyl)-4-piperidinyl]oxy]-1H-indol-2-yl]-
- 63435-76-7/Benzenecarboximidamide, 4,4'-[(2-oxo-1,3-cycloheptanediylidene)dimethylidyne]bis-
- 206352-85-4/1(2H)-Pyridineacetamide, N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-thiazolylcarbonyl)butyl]-2-oxo-3-[[(phenylmethyl)sulfonyl]amino]-
- 334953-11-6/Glycinamide, 3-[1-(aminoiminomethyl)-4-piperidinyl]-N-[(phenylmethyl)sulfonyl]-D-alanyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-formylbutyl]- (9CI)
- 186304-04-1/N2-[(Phenylmethyl)sulfonyl]-D-arginyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-thiazolylcarbonyl)butyl]glycinamide
- 637328-69-9/Tanogitran
- 1004990-28-6/1L-6-HYDROXYMETHYL-CHIRO-INOSITOL 2-(R)-2-O-METHYL-3-O-OCTADECYLCARBONATE
- 845614-11-1/[4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-Methylsulfonyl-2-[((S)-2,2,2-trifluoro-1-methylethyl)oxy]phenyl]methanone
- 845609-54-3/4-[4-[2-(Cyclopropylmethoxy)-5-methylsulfonylbenzoyl]piperazin-1-yl]-3-fluorobenzonitrile
- 556113-62-3/(2R)-4-[5-Chloro-2-[(4-methoxyphenyl)thio]phenyl]-2-methyl-1-piperazineacetic acid
- 722456-08-8/Org 24598 lithium salt
- 372198-97-5/N-Methyl-N-[(3R)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]glycine
- 34042-00-7/DL-BETA-HYDROXYNORVALINE
- 1109-96-2/Silicic acid, ethyl ester
- 692764-89-9/5-(4-Methoxy[1,1'-biphenyl]-3-yl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide
- 612530-44-6/5-Phenyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide
- 941607-78-9/5-[4-(Cyclohexylmethyl)-2-fluoro-6-hydroxyphenyl]-1,2,5-thiadiazolidin-3-one 1,1-dioxide
- 327033-16-9/4-Thiazolidinone, 3-(3-chlorophenyl)-5-[(4-hydroxy-3-methoxy-5-nitrophenyl)methylene]-2-thioxo-
- 446043-04-5/[1,1':4',1''-Terphenyl]-3-methanesulfonic acid, α,α-difluoro-, ammonium salt (9CI)
- 1000611-47-1/Pentanoic acid, 2-[[[(1S)-1-(4-ethyl-2-thiazolyl)-2-[4-(sulfoamino)phenyl]ethyl]amino]carbonyl]-4-methyl-, 1-methyl ester, (2S)-
- 875662-69-4/Sulfamic acid, N-[3-[3-[(3S)-3,4-dihydro-3-[(methylamino)carbonyl]-7-(sulfoamino)-2(1H)-isoquinolinyl]-3-oxopropyl]phenyl]-